Cross Country's 3Q In-Line With Estimates

Oppenheimer has published a research report on Cross Country Healthcare, Inc. CCRN after the company reported its 3Q with in-line earnings with Oppenheimer and the Street. In the report, Oppenheimer writes "CCRN reported Q3:10 EPS of $0.03, in line with our estimate and Street consensus. Weakness in the housing and labor markets continue to pressure demand for nurse, allied and physician staffing services. While the business does not appear to be bouncing back, management noted signs of improvement and stabilization. CCRN updated its guidance range and now expects Q4:10 and FY10 EPS of $0.01-$0.03 and $0.11-$0.13, on revenues of $113-$116M and $468-$471M, respectively. As a result, we are tweaking our FY2010 and FY2011 EPS estimates to $0.12 and $0.23, down from $0.17 and $0.28, respectively." Oppenheimer maintains its Perform rating on Cross Country Healthcare, which closed yesterday at $6.85.